Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter (Q39882572)

15 September 2017

title

Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter (English)

1 reference

15 September 2017

Young-Eun Choi

1

1 reference

15 September 2017

Ha-Nul Yu

series ordinal

2

1 reference

15 September 2017

Cheol-Hee Yoon

series ordinal

3

1 reference

15 September 2017

Yong-Soo Bae

series ordinal

4

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

European Journal of Immunology

15 September 2017

published in

1 reference

15 September 2017

volume

39

1 reference

15 September 2017

issue

3

1 reference

15 September 2017

page(s)

858-868

1 reference

Lessons from the bare lymphocyte syndrome: molecular mechanisms regulating MHC class II expression.

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Regulation of MHC class II gene expression by the class II transactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Quantitative control of MHC class II expression by the transactivator CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Class II transactivator regulates the expression of multiple genes involved in antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Antigen presentation and T cell stimulation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Mechanisms and functional significance of tumour-induced dendritic-cell defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Genetic control of MHC class II expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Enhanced production of IL-10 by dendritic cells deficient in CIITA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Regulation of Th2 differentiation and Il4 locus accessibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Haematopoietic cell-fate decisions, chromatin regulation and ikaros

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

A murine renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

7 January 2021

Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

7 January 2021

The IL-7 receptor controls the accessibility of the TCRgamma locus by Stat5 and histone acetylation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

7 January 2021

IL-10 prevents the generation of dendritic cells from CD14+ blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838674

7 January 2021

Identifiers

DOI

10.1002/EJI.200838674

1 reference

15 September 2017

1 reference